ROYAL BANK OF CANADA - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$16,000
-87.7%
461
-91.7%
0.00%
Q1 2021$130,000
+78.1%
5,527
+120.4%
0.00%
Q4 2020$73,000
+180.8%
2,508
+91.2%
0.00%
Q3 2020$26,000
-63.9%
1,312
-44.6%
0.00%
Q2 2020$72,000
+30.9%
2,369
+35.8%
0.00%
Q1 2020$55,0000.0%1,744
+48.4%
0.00%
Q4 2019$55,000
+48.6%
1,175
-79.6%
0.00%
Q3 2019$37,0005,750
+31844.4%
0.00%
Q2 2019$0
-100.0%
18
-92.7%
0.00%
Q4 2018$1,0000.0%246
+112.1%
0.00%
Q3 2018$1,0001160.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q1 2021
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders